Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa - PubMed (original) (raw)

Review

Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa

S A Khader et al. Mucosal Immunol. 2009 Sep.

Abstract

T helper type 17 (Th17) cells are a distinct lineage of T cells that produce the effector molecules IL-17, IL-17F, IL-21, and IL-22. Although the role of Th17 cells in autoimmunity is well documented, there is growing evidence that the Th17 lineage and other interleukin (IL)-17-producing cells are critical for host defense against bacterial, fungal, and viral infections at mucosal surfaces. Here we summarize recent progress in our understanding of the function of IL-17-producing cells as a bridge between innate and adaptive immunity against infectious diseases at the mucosa.

PubMed Disclaimer

Figures

Figure 1

Figure 1. Current understanding of T-helper cell differentiation

Naïve CD4+ T cells, after activation by signaling via the T-cell Receptor and co-stimulatory molecules such as CD28 and Cytotoxic T lymphocyte-associated protein 4 (CTLA-4), can differentiate into three lineages of effector T helper(Th) cells namely Th1, Th2 or Th17 cells. Th subsets produce different cytokines and have distinct immunoregulatory functions. Th2 cells produce IL-4, IL-5 and IL-10 and promote immunity against parasites such as helminths. Th1 cells produce IFNγ and TNF-α and provide immunity against intracellular pathogens. Th17 cells produce the cytokines IL-17/IL-17F, IL-22, IL-21 and TNF-α and primarily promote immunity against extracellular pathogens.

Figure 2

Figure 2. Role of Th17 cytokines in protective immunity at the mucosa

Infection-induced IL-17 and IL-22 can be produced by several immune cells found in mucosal sites. A critical likely target of IL-17 and IL-22 is the mucosal epithelium where IL-17 augments G-CSF and CXC chemokine production resulting in recruitment of neutrophils that contribute to bacterial and fungal clearance at mucosal sites. IL-22 along with IL-17 also augments antimicrobial peptides and epithelial repair function important for control of extracellular fungal pathogens. In the setting of vaccine-induced immunity, Th17 cells can induce the production of ligands for CXCR3 and augment the recruitment of IFNγ producing Th1 cells to control intracellular pathogen growth.

Similar articles

Cited by

References

    1. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136:2348–57. - PubMed
    1. Garvy BA, Wiley JA, Gigliotti F, Harmsen AG. Protection against Pneumocystis carinii pneumonia by antibodies generated from either T helper 1 or T helper 2 responses. Infect Immun. 1997;65:5052–6. - PMC - PubMed
    1. Langrish CL, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005;201:233–40. - PMC - PubMed
    1. Harrington LE, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123–32. - PubMed
    1. Park H, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6:1133–41. - PMC - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources